Anti-TEX261 monoclonal antibody

Pre-made anti-TEX261 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to TEX261/TEX261 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1906-Ab-1/ GM-Tg-hg-IP1906-Ab-2Anti-Human TEX261 monoclonal antibodyHuman
GM-Tg-rg-IP1906-Ab-1/ GM-Tg-rg-IP1906-Ab-2Anti-Rat TEX261 monoclonal antibodyRat
GM-Tg-mg-IP1906-Ab-1/ GM-Tg-mg-IP1906-Ab-2Anti-Mouse TEX261 monoclonal antibodyMouse
GM-Tg-cynog-IP1906-Ab-1/ GM-Tg-cynog-IP1906-Ab-2Anti-Cynomolgus/ Rhesus macaque TEX261 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1906-Ab-1/ GM-Tg-felg-IP1906-Ab-2Anti-Feline TEX261 monoclonal antibodyFeline
GM-Tg-cang-IP1906-Ab-1/ GM-Tg-cang-IP1906-Ab-2Anti-Canine TEX261 monoclonal antibodyCanine
GM-Tg-bovg-IP1906-Ab-1/ GM-Tg-bovg-IP1906-Ab-2Anti-Bovine TEX261 monoclonal antibodyBovine
GM-Tg-equg-IP1906-Ab-1/ GM-Tg-equg-IP1906-Ab-2Anti-Equine TEX261 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1906-Ab-1/ GM-Tg-hg-IP1906-Ab-2; GM-Tg-rg-IP1906-Ab-1/ GM-Tg-rg-IP1906-Ab-2;
GM-Tg-mg-IP1906-Ab-1/ GM-Tg-mg-IP1906-Ab-2; GM-Tg-cynog-IP1906-Ab-1/ GM-Tg-cynog-IP1906-Ab-2;
GM-Tg-felg-IP1906-Ab-1/ GM-Tg-felg-IP1906-Ab-2; GM-Tg-cang-IP1906-Ab-1/ GM-Tg-cang-IP1906-Ab-2;
GM-Tg-bovg-IP1906-Ab-1/ GM-Tg-bovg-IP1906-Ab-2; GM-Tg-equg-IP1906-Ab-1/ GM-Tg-equg-IP1906-Ab-2
Products NameAnti-TEX261 monoclonal antibody
Formatmab
Target NameTEX261
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-TEX261 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1906-Ag-1Recombinant multi-species TX261/ TEX261/ TEG-261 protein
    ORF Viral VectorpGMAAV000336Norway rat Tex261 AAV plasmid
    ORF Viral VectorvGMAAV000336Norway rat Tex261 AAV particle


    Target information

    Target IDGM-IP1906
    Target NameTEX261
    Gene ID113419,21766,297392,703863,481425,101098533,514869,100060120
    Gene Symbol and Synonyms3110001O07Rik,TEG-261,TEX261
    Uniprot AccessionQ6UWH6,Q5BJW3,Q58DA4
    Uniprot Entry NameTX261_HUMAN,TX261_RAT,TX261_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000144043
    Target ClassificationN/A

    The target: TEX261, gene name: TEX261, also named as TEG-261. Predicted to enable COPII receptor activity. Predicted to be involved in endoplasmic reticulum to Golgi vesicle-mediated transport. Predicted to act upstream of or within positive regulation of apoptotic process. Predicted to be located in cytoplasm. Predicted to be integral component of membrane. Predicted to be active in COPII-coated ER to Golgi transport vesicle. Predicted to be integral component of Golgi membrane and integral component of endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.